Stocks
Intra-Cellular Therapies (ITCI) Net margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -243 714% | -1 008% | -347.7% | -102.9% | -30.1% | -14.1% | ||
| Changes by years, y/y, % | +242 706pp | +660pp | +245pp | +73pp | -89.5% | ||||
Intra-Cellular Therapies. Net margin, %
Intra-Cellular Therapies. Net margin, changes, pp
Intra-Cellular Therapies (ITCI) Net margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Net margin, % | ? | -19.3% | -21.7% | -10.5% | -10.1% | -15.0% | -14.1% | |
| Changes by years, y/y, % | +55pp | +21pp | +36pp | +29pp | +4pp | |||
| Changes by quarters, q/q, % | +20pp | -2pp | +11pp | +0pp | -5pp | |||
